The organisation was founded in 2004 in memory of filmmaker Richard Coker
The Richard Coker Foundation has officially become a registered UK charity, marking a significant moment in its 22-year mission to improve the lives of people affected by sickle cell disease and inherited blood disorders in the UK and internationally.
Now registered with the Charity Commission under Charity Number 1215492, the foundation enters a new phase of growth, strengthening its work across public health, education, research, screening, genetic counselling and community support. The move formalises decades of grassroots and international advocacy while positioning the organisation for wider national and global impact.
Founded in 2004 in memory of filmmaker Richard Coker, who died aged 32 following complications related to sickle cell disease, the foundation was established to honour his life, creativity and quiet resilience. His legacy continues to shape the charity’s work, rooted in dignity, access to care and global solidarity for individuals and families living with inherited blood conditions.
The foundation was set up by Richard’s mother, broadcaster, musician and cultural figure Dame Julie Coker, (pictured top) alongside his lifelong collaborator, cousin and close friend Baba-Jallah Epega. Together with family and friends, they sought to ensure that Richard’s life would continue to make a tangible difference beyond his years. For Epega, now a co-founder and trustee, the charity represents a lifelong commitment shaped by friendship and shared purpose.
“Richard was one of the most courageous people I have ever known,” Epega said. “Even as a child, he carried himself with dignity and quiet strength. Standing beside him taught me what it means to lead with compassion and integrity.”
Today, the Richard Coker Foundation focuses on public health education, supporting screening and genetic counselling programmes, funding and disseminating research, and providing emotional and peer-based support for those affected.
The organisation is a member of Sickle Cell Alliance UK and works in collaboration with institutions including the Imperial Sickle Cell Group, underlining its commitment to ethical and evidence-led practice.
Trustee Olatunji Bada said the registration marks a beginning rather than a conclusion: “This is not an endpoint. It is our responsibility to honour Richard’s life through action and to serve communities too often overlooked.”
As it enters this new chapter, the foundation is calling on healthcare bodies, policymakers, funders and partners worldwide to help build a future in which no one living with inherited blood disorders is left behind.
